Evidence map›Paper›PMID 27317686›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2016

Ibuprofen regulation of microtubule dynamics in cystic fibrosis epithelial cells.

Sharon M Rymut, Claire M Kampman, Deborah A Corey, Tori Endres, Calvin U Cotton, Thomas J Kelley

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. HDAC6 inhibition reducesInfection and immunity · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Carbonic anhydrase and soluble adenylate cyclase regulation of cystic fibrosis cellular phenotypes.American journal of physiology. Lung cellular and molecular physiology · 2022
    Article
  8. Review
  9. Chronic rhinosinusitis in cystic fibrosis: a review of therapeutic options.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Review
  10. Review
  11. Review
  12. Article
  13. Resveratrol restores intracellular transport in cystic fibrosis epithelial cells.American journal of physiology. Lung cellular and molecular physiology · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sharon M RymutDepartments of Pediatrics, Case Western Reserve University, Cleveland, Ohio.
Claire M KampmanDepartments of Pediatrics, Case Western Reserve University, Cleveland, Ohio.
Deborah A CoreyDepartments of Pediatrics, Case Western Reserve University, Cleveland, Ohio.
Tori EndresDepartments of Pediatrics, Case Western Reserve University, Cleveland, Ohio.
Calvin U CottonDepartments of Pediatrics, Case Western Reserve University, Cleveland, Ohio.
Thomas J KelleyDepartments of Pediatrics, Case Western Reserve University, Cleveland, Ohio thomas.kelley@case.edu.
Case Western Reserve University · US

Funding

Translational Research in Cystic FibrosisP30DK027651 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI DRUMM, MITCHELL L · 1986 to 2014
$15.6M
Dysregulation of Nrf2 in CF epitheliaR01HL109362 · NHLBI · EMORY UNIVERSITY · PI ZIADY, ASSEM G · 2011 to 2014
$1.5M
CYTO VISION WORKSTATION FOR USE IN MULTI-USER FACILITY: CYSTIC FIBROSISS10RR021228 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI CONRAD, PATRICIA A · 2005 to 2005
$178k
NCRR NIH HHS S10 RR021228NHLBI NIH HHS R01 HL109362NIDDK NIH HHS P30 DK027651
6 · The paper itself

Abstract

High-dose ibuprofen, an effective anti-inflammatory therapy for the treatment of cystic fibrosis (CF), has been shown to preserve lung function in a pediatric population. Despite its efficacy, few patients receive ibuprofen treatment due to potential renal and gastrointestinal toxicity. The mechanism of ibuprofen efficacy is also unclear. We have previously demonstrated that CF microtubules are slower to reform after depolymerization compared with respective wild-type controls. Slower microtubule dynamics in CF cells are responsible for impaired intracellular transport and are related to inflammatory signaling. Here, it is identified that high-dose ibuprofen treatment in both CF cell models and primary CF nasal epithelial cells restores microtubule reformation rates to wild-type levels, as well as induce extension of microtubules to the cell periphery. Ibuprofen treatment also restores microtubule-dependent intracellular transport monitored by measuring intracellular cholesterol transport. These effects are specific to ibuprofen as other cyclooxygenase inhibitors have no effect on these measures. Effects of ibuprofen are mimicked by stimulation of AMPK and blocked by the AMPK inhibitor compound C. We conclude that high-dose ibuprofen treatment enhances microtubule formation in CF cells likely through an AMPK-related pathway. These findings define a potential mechanism to explain the efficacy of ibuprofen therapy in CF.

Indexed as

AcetylationAdenylate KinaseCell LineCyclooxygenase InhibitorsCystic FibrosisDrug Evaluation, PreclinicalEnzyme ActivationEpithelial CellsGuanine Nucleotide Exchange FactorsHumansIbuprofenMicrotubulesPrimary Cell CultureProtein MultimerizationProtein Processing, Post-TranslationalShelterin ComplexAdenylate KinaseCyclooxygenase InhibitorsGuanine Nucleotide Exchange FactorsIbuprofenRAPGEF3 protein, humanShelterin ComplexTelomere-Binding ProteinsTERF2IP protein, humancystic fibrosisibuprofenmicrotubule

Identifiers

PMID27317686
PMCPMC5142453
OpenAlexW2420103240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.